Clinical Trial Update: Niclosamide in Pediatric Patients With Relapsed and Refractory AML [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating niclosamide in pediatric patients with relapsed or refractory acute myeloid leukemia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Niclosamide (niclosamide)

Snippet

Sponsor: Stanford University | Conditions: Acute Myeloid Leukemia (AML) | Phase 1 | Status: RECRUITING